Ultime notizie per WGE Holdings (OTC:WGEE) Azioni

WGE Holdings Corp is a holding company. The company is seeking acquisitions and other business ventures throughout the country. It has acquired Far East Ventures Holdings, a company that owns certain mining assets. It is also in the process of developing a platform of gold production facilities in Indonesia and the Philippines.

WGE Holdings Corp

Earnings

News

Optical Cable Q2 EPS $(0.09) Up From $(0.21) YoY, Sales $17.55M Up From $16.11M YoY

Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.67, a high estimate of $30.00, and a low estimate of $23.00. Highlighting a 17.31% decrease, the current average has fallen from the previous average price target of $34.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1749124883_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Verint Systems among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$30.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Dan Bergstrom</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$29.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Peter Levine</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$23.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Verint Systems. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Verint Systems compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Verint Systems's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Verint Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VRNT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Verint Systems analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Verint Systems's Background</h2>
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
<h3>Verint Systems: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Decline in Revenue: Over the 3M period, Verint Systems faced challenges, resulting in a decline of approximately -4.36% in revenue growth as of 31 January, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Verint Systems's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.35% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Verint Systems's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.26% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Verint Systems's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.27% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Verint Systems's debt-to-equity ratio is below the industry average at 0.51, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

VRNT

6 Analysts Have This To Say About Verint Systems

Across the recent three months, 14 analysts have shared their insights on MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $249.79, along with a high estimate of $330.00 and a low estimate of $160.00. A 16.34% drop is evident in the current average compared to the previous average price target of $298.57. 
<img src="https://www.benzinga.com/files/images/story/2025/1749124864_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of MongoDB among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$290.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$270.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Howard Ma</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$235.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Yun Kim</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$190.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$252.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$160.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Matthew Broome</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$275.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$330.00</td>
<td>$430.00</td>
</tr>
<tr>
<td>Miller Jump</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$275.00</td>
<td>$300.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MongoDB. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MongoDB compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of MongoDB's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MongoDB's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MDB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MongoDB analyst ratings.</a>
<h2>Delving into MongoDB's Background</h2>
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.
<h3>Understanding the Numbers: MongoDB's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3M period, MongoDB showcased positive performance, achieving a revenue growth rate of 19.74% as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: MongoDB's net margin excels beyond industry benchmarks, reaching 2.89%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.74%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): MongoDB's ROA stands out, surpassing industry averages. With an impressive ROA of 0.48%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: MongoDB's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About MongoDB Stock

Dollar Tree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) presented its &#8220;5 levers mitigation strategy&#8221; to address Donald Trump&#8217;s &#8220;highly fluid and changing&#8221; tariff scenario during its <a href="https://www.benzinga.com/markets/earnings/25/06/45768682/dollar-tree-q1-same-store-sales-jump-5-4-warns-of-near-term-profit-drop-on-tariff-pressure-transition-costs">first quarter earnings</a> call and highlighted its impact on second quarter profits.
What Happened: The company&#8217;s CEO and Director, Michael Creedon, explained that the available &#8220;5 levers&#8221; are being utilized to address cost inflation.
This included negotiating with suppliers, respeccing products (meaning re-specifying or redesigning products cost-effectively, moving the country of origin, dropping non-economic items, and leveraging our expanded multi-price capabilities.
The CEO also underscored that the volatility of today&#8217;s operating environment, especially with &#8220;highly fluid and changing&#8221; tariffs, made it harder to predict the second quarter performance.
&#8220;Stepping back and taking a full-year view, we believe that by successfully deploying our 5 levers, we will be able to mitigate most, if not all, of the potential earnings impact from higher tariffs, assuming the current levels remain in place,&#8221; he said.
According to the CFO, Stewart Glendinning, &#8220;We expect our second quarter profits to be meaningfully lower than last year in light of higher tariffs and other costs, including some costs we absorbed during the 145% window on China tariffs.&#8221;
Additionally, the CEO also highlighted the rise in &#8220;meaningful traffic Increase&#8221; from customers with household incomes of more than $100,000, demonstrating Dollar Tree&#8217;s broad appeal.
He added, highlighting these details that &#8220;Our customers need us now more than ever. Each week, more shoppers across a diverse range of economic and demographic backgrounds are responding to the appeal of Dollar Tree&#8217;s unique value, convenience, and discovery proposition.&#8221;
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/45764818/bill-ackman-urges-end-to-fannie-mae-freddie-mac-conservatorship-says-will-enable-them-to-operate-more-successfully-and-efficiently">Bill Ackman Urges End To Fannie Mae, Freddie Mac Conservatorship: Says Will Enable Them To &#8216;Operate More Successfully And Efficiently&#8217;</a>
Why It Matters: Dollar Tree&#8217;s <a href="https://www.benzinga.com/markets/earnings/25/06/45768682/dollar-tree-q1-same-store-sales-jump-5-4-warns-of-near-term-profit-drop-on-tariff-pressure-transition-costs">first quarter results</a> exceeded forecasts, with net sales up 11.3% to $4.6 billion, surpassing both analyst consensus and company guidance.
Same-store sales jumped 5.4% above guidance, fueled by a 2.5% increase in traffic and a 2.8% rise in average ticket. The company also reported adjusted earnings of $1.26 per share, beating both analyst estimates and management&#8217;s outlook.
However, it reiterated full-year sales guidance in the range of $18.5 billion to $19.1 billion. This forecast fell short of the average analyst estimate of $18.95 billion, leading to investor disappointment.
Thus, the stock closed 8.37% lower on Wednesday. It was up 15.89% on a year-to-date basis and 22.52% lower over a year.
Benzinga Edge Stock Rankings shows that DLTR had a stronger price trend over the short, medium, and long term. Its value ranking was moderate at the 62.97th percentile, whereas its growth ranking was poor. The details of other metrics for this and many other stocks are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="158" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/05022153/DLTR-Edge-1024x158.png" alt="" class="wp-image-939206" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/05022153/DLTR-Edge-1024x158.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/05022153/DLTR-Edge-300x46.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/05022153/DLTR-Edge-768x119.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/05022153/DLTR-Edge.png 1153w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, ended on a mixed note on Wednesday. The SPY was down 0.027% at $595.93, while the QQQ advanced 0.28% to $528.77, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/06/45769560/crwv-stock-hits-new-all-time-high-on-7-billion-apld-deal-technical-indicators-flash-bullish-signal-but-rsi-warns-caution-on-coreweave">CRWV Stock Hits New All-Time High On $7 Billion APLD Deal: Technical Indicators Flash Bullish Signal, But RSI Warns Caution On CoreWeave </a></li>
</ul>
Photo courtesy: Around the World Photos / Shutterstock.com

DLTR

Dollar Tree Unveils '5-Lever Mitigation Strategy' To Address Trump's Tariffs: Warns of 'Meaningfully Lower' Q2 Profit

In the latest quarter, 5 analysts provided ratings for J.Jill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JILL#NYSE">JILL</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.0, a high estimate of $31.00, and a low estimate of $21.00. This current average represents a 11.56% decrease from the previous average price target of $29.40. 
<img src="https://www.benzinga.com/files/images/story/2025/1749124840_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of J.Jill by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Corey Tarlowe</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$21.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$31.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$31.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to J.Jill. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of J.Jill compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of J.Jill's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into J.Jill's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/JILL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on J.Jill analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About J.Jill</h2>
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
<h3>J.Jill: Delving into Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: J.Jill's revenue growth over a period of 3M has faced challenges. As of 31 January, 2025, the company experienced a revenue decline of approximately -4.95%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: J.Jill's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 1.57%, the company may face hurdles in effective cost management.
Return on Equity (ROE): J.Jill's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.15%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): J.Jill's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.54%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.97, J.Jill faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JILL

A Glimpse Into The Expert Outlook On J.Jill Through 5 Analysts

6 analysts have expressed a variety of opinions on Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.72, a high estimate of $8.00, and a low estimate of $3.50. This current average represents a 5.75% decrease from the previous average price target of $7.13. 
<img src="https://www.benzinga.com/files/images/story/2025/1749124830_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Planet Labs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Noah Poponak</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$3.50</td>
<td>$6.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Trevor Walsh</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$6.50</td>
<td>$6.50</td>
</tr>
<tr>
<td>Colin Canfield</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$6.30</td>
<td>$6.30</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Planet Labs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Planet Labs compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Planet Labs's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Planet Labs's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Planet Labs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Planet Labs</h2>
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy &amp; Infrastructure, Forestry &amp; Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense &amp; Intelligence, and Armed Services.
<h3>Planet Labs's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Planet Labs displayed positive results in 3M. As of 31 January, 2025, the company achieved a solid revenue growth rate of approximately 4.59%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -57.11%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Planet Labs's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -7.76%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -5.56%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Planet Labs Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

JMP Securities analyst Jordan Bender maintains DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) with a Market Outperform and lowers the price target from $54 to $50.

Price Target

DKNG

JMP Securities Maintains Market Outperform on DraftKings, Lowers Price Target to $50

Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) will release its second-quarter financial results after the <a href="https://www.benzinga.com/content/45776705/broadcom-earnings-preview-avgo-stock-near-record-highs">closing bell on Thursday, June 5</a>.
Some investors may be eyeing potential gains from the Palo Alto, California-based company's dividends. Currently, Broadcom offers an annual dividend yield of 0.90%. That&#8217;s a quarterly dividend amount of 59 per share ($2.36 a year).
To figure out how to earn $500 monthly from Broadcom, we start with a yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Broadcom's $2.36 dividend: $6,000 / 2.36 = 2,542 shares.
So, an investor would need to own approximately $663,665 worth of Broadcom, or 2,542 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $2.36 = 508 shares, or $132,629 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
AVGO Price Action: Shares of Broadcom gained by 1.7% to close at $261.08 on Wednesday.
Analysts expect Broadcom to report quarterly earnings at $1.57 per share, up from $1.10 per share in the year-ago period. Broadcom projects quarterly revenue of $14.97 billion, compared to $12.49 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company beat analyst estimates in the first quarter and has beaten analyst estimates for revenue in eight of the last 10 quarters overall
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45767953/jim-cramer-arrowhead-pharmaceuticals-doesnt-have-the-horses">Jim Cramer: Arrowhead Pharmaceuticals Doesn&#8217;t &#8216;Have The Horses</a>&#8216;</li>
</ul>
Image: Shutterstock

Long Ideas

Dividends

Markets

Trading Ideas

AVGO

How To Earn $500 A Month From Broadcom Stock Ahead Of Q2 Earnings

Wedbush analyst David Nierengarten initiates coverage on Telix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) with a Outperform rating and announces Price Target of $22.

Initiation

Wedbush Initiates Coverage On Telix Pharmaceuticals with Outperform Rating, Announces Price Target of $22

Taking risks vs. staying safe: it&#8217;s an age old dilemma that no human being can avoid. But for Bill Gates, the choice is obvious. Risk, Gates says, is essential to progress, and anyone who advices against it should not be paid heed. What Happened: During a podcast <a href="https://www.youtube.com/watch?v=pBRSZBtirAk&amp;t=4411s">episode</a> with Jay Shetty, Bill Gates, the billionaire co-founder of Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) shared the worst advice he ever received, saying, &#8220;People will tell you not to take risks and it&#8217;s very well-intentioned.&#8221;
Gates highlighted that sometimes, the advice people give is not meant to hurt, but to protect. He argued that there are contexts where taking risks is essential, and that risk isn&#8217;t like a &#8220;flesh wound&#8221;. Gates emphasized that failure is a better teacher than success, noting that society has gone too far in prioritizing physical or emotional safety, and that has stopped people from taking risks.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/45788610/ai-for-the-masses-humans-for-the-elite-klarna-ceo-details-dual-tier-strategy-amid-growing-demand-for-human-connection">AI For The Masses, Humans For The Elite: Klarna CEO Details Dual-Tier Strategy Amid Growing Demand For Human Connection</a> Why It Matters: Gates often doles out life advice during media appearances. During one such appearance, his advice to someone who wanted to become like him was clear: beyond a certain point, <a href="https://www.benzinga.com/personal-finance/25/02/43562104/bill-gates-was-the-richest-man-in-the-world-for-a-record-18-years-he-says-money-brings-freedom-but-beyond-that-its-the-same-hamburger">more money doesn&#8217;t buy more happiness</a>—or better burgers. Gates acknowledges that financial freedom matters, <a href="https://www.benzinga.com/personal-finance/25/04/45056962/bill-gates-says-hes-happier-as-a-billionaire-than-if-he-were-middle-class-you-dont-need-a-billionbut-freedom-from-worry-is-a-blessing">but freedom from worries</a> like health or college costs is &#8220;a real blessing.&#8221; Recently Gates <a href="https://www.benzinga.com/25/05/45377433/bill-gates-announces-plan-to-close-the-gates-foundation-says-hell-give-away-virtually-all-of-his-wealth-over-the-next-20-years">announced </a>that he intends to give away 99% of his $168 billion fortune over the next 20 years. This week, he shared that the majority of the amount would be <a href="https://www.benzinga.com/news/esg/25/06/45739698/bill-gates-commits-majority-of-200-billion-foundation-budget-to-africa-over-next-20-years-amid-trumps-massive-usaid-cuts">channeled to Africa. </a>
Photo Courtesy: Alexandros Michailidis on Shutterstock Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/06/45789143/abu-dhabis-irh-buys-majority-stake-in-alphamins-tin-operations-in-366-million-deal">Abu Dhabi&#8217;s IRH Buys Majority Stake In Alphamin&#8217;s Tin Operations In $366 Million Deal</a></li>
</ul>

Education

Tech

MSFT

Bill Gates Says The Worst Advice He Received Was To Avoid Risk: 'What Better Teacher Than Failure?

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/06/04/final-trades-dell-equinix-wabtec-and-guidewire-software.html">Halftime Report Final Trades</a>,&#8221; Bryn Talkington, managing partner at Requisite Capital Management, said Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) is a great company to own <a href="https://www.benzinga.com/quote/DELL/earnings">in the long term.</a>
Supporting her view, Dell, on May 29, reported first-quarter revenue of $23.38 billion, beating the consensus estimate of $23.14 billion, according to Benzinga Pro. 
Dell expects fiscal 2026 revenue of $101 billion to $105 billion and full-year adjusted earnings of $9.40 per share.
Sarat Sethi, DCLA managing partner and portfolio manager, picked data centers, and said Equinix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) is the company to play in that.
Lending support to his choice, Equinix, on April 30, posted better-than-expected financial results&nbsp; for the first quarter.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal, Chief Equity Strategist at Cerity Partners, said Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) is just a solid industrial stock.
On the earnings front, Westinghouse Air Brake, on April 23, reported better-than-expected first-quarter adjusted EPS results and raised its FY25 adjusted EPS guidance.
Joseph M. Terranova, Senior Managing Director for Virtus Investment Partners, named Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) as his final trade.
Guidewire Software shares rose sharply on Wednesday after the company reported better-than-expected third-quarter earnings on Tuesday after the market closed.
Price Action:
<ul class="wp-block-list">
<li>Dell shares gained 0.7% to close at $112.70 on Wednesday.</li>
<li>Equinix rose 1.9% to close at $912.20 on Wednesday.</li>
<li>Wabtec shares gained 0.2% to close at $203.94 during the session.</li>
<li>Guidewire Software shares jumped 16.4% to settle at $253.98.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45767953/jim-cramer-arrowhead-pharmaceuticals-doesnt-have-the-horses">Jim Cramer: Arrowhead Pharmaceuticals Doesn&#8217;t &#8216;Have The Horses&#8217;</a></li>
</ul>
Image: Shutterstock

Media

DELL

EQIX

GWRE

Dell, Equinix, Guidewire Software And An Industrial Stock: CNBC's 'Final Trades'

Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) on Wednesday announced the acquisition of Brium, a team of compiler and AI software experts with deep expertise in machine learning, AI inference, and performance optimization.
The financial terms of the <a target="_blank" href="https://www.amd.com/en/blogs/2025/amd-acquires-brium-to-strengthen-open-ai-software-ecosystem.html" rel="noreferrer noopener">transaction</a> remain undisclosed.
Brium brings advanced software capabilities that strengthen AMD&#8217;s ability to deliver highly optimized AI solutions across the entire stack.
Their work in compiler technology, model execution frameworks, and end-to-end AI inference optimization will play a key role in enhancing the efficiency and flexibility of AMD&#8217;s AI platform.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45753565/rubrik-teams-up-with-amd-to-power-ai-ready-cost-effective-cloud-security-solutions" rel="noreferrer noopener">Rubrik Teams Up With AMD To Power AI-Ready, Cost-Effective Cloud Security Solutions</a>
The acquisition marks the latest in a series of targeted investments, following AMD&#8217;s acquisitions of Silo AI, Nod.ai, and Mipsology, that boosts its ability to support the open-source software ecosystem and deliver optimized performance on its hardware.
Last week, AMD <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45664165/amd-deepens-ai-ecosystem-with-enosemi-acquisition" rel="noreferrer noopener">announced the acquisition</a> of&nbsp;Enosemi, a move to accelerate&nbsp;co-packaged optics innovation for AI systems. The financial terms of the deal remain undisclosed.
AMD held $6.06 billion in&nbsp;cash and equivalents&nbsp;as of March 29, 2025. AMD stock plunged 29% in the last 12 months as it grappled with intensifying rivalry from Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), a cooling tech rally, and the Trump administration&#8217;s tariff policies.
AMD reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45237261/amd-q1-earnings-revenue-eps-beat-driven-by-expanding-data-center-ai-momentum-chipmaker-expects-strong-growth-in-2025" rel="noreferrer noopener">first-quarter revenue</a> of $7.44 billion, up 36%, beating&nbsp;analyst estimates of $7.13 billion. The chipmaker reported first-quarter adjusted earnings of 96 cents per share, beating analyst estimates of 94 cents per share.
AMD expects second-quarter revenue of approximately $7.4 billion, plus or minus $300 million. Analysts are currently forecasting second-quarter revenue of $7.24 billion.
Price Action: AMD stock is trading higher by 0.42% to $119.08 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45781527/apple-app-store-sales-jump-in-may-boosting-outlook-for-services-growth" target="_blank" rel="noreferrer noopener">Apple App Store Sales Jump In May, Boosting Outlook For Services Growth</a></li>
</ul>
Photo by jamesonwu1972 via Shutterstock

NVDA

AMD Acquires Another Company To Expand AI Arsenal

Jacobs Chosen To Deliver Design, Engineering And Environmental Services For Boeing's Multi-Billion Expansion At St. Louis, Missouri, Campus

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said he likes Dominion Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>). &#8220;It's fine. For a while, I was worried about the balance sheet. I think <a href="https://www.benzinga.com/quote/D/news">we're ok,&#8221; he added</a>.
Supporting his view, Dominion Energy, on May 1, reported first-quarter revenue of $4.076 billion, beating the consensus of $3.97 billion. Adjusted EPS was 93 cents, up from 55 cents a year ago, beating the consensus of 75 cents. The company reaffirmed its 2025 operating earnings guidance range to $3.28 – $3.52 per share (consensus $3.39).
Cramer said he is &#8220;not a fan&#8221; of Iron Mountain Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>), as its yield is &#8220;too low.&#8221;
On the earnings front, Iron Mountain, on May 1, posted first-quarter adjusted earnings of 43 cents per share, beating market estimates of 40 cents per share. 
The company's quarterly sales came in-line with estimates at $1.59 billion. Iron Mountain raised its FY2025 AFFO guidance from $4.85-$4.95 to $4.95-$5.05 and also boosted its FY2025 sales guidance from $6.65 billion-$6.80 billion to $6.74 billion-$6.89 billion.
Price Action:
<ul class="wp-block-list">
<li>Dominion Energy shares fell 1.1% to settle at $56.08 on Wednesday.</li>
<li>Iron Mountain gained 0.3% to settle at $100.21 on Wednesday.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45767953/jim-cramer-arrowhead-pharmaceuticals-doesnt-have-the-horses">Jim Cramer: Arrowhead Pharmaceuticals Doesn&#8217;t &#8216;Have The Horses&#8217;</a></li>
</ul>
Image: Shutterstock

Jim Cramer Likes Dominion Energy, But Isn't 'A Fan' Of This Real Estate Stock

D. Boral Capital analyst Jason Kolbert maintains Immunic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMUX#NASDAQ">IMUX</a>) with a Buy and maintains $10 price target.

IMUX

D. Boral Capital Maintains Buy on Immunic, Maintains $10 Price Target

Telomir Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELO#NASDAQ">TELO</a>) on Thursday released new preclinical data for its lead candidate, Telomir-1.
The data demonstrated that Telomir-1, administered orally, significantly increases telomere length, reverses body weight and muscle loss, and resets cellular aging markers in a validated animal model of Werner Syndrome (WS)—a rare genetic disorder also known as <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">adult-onset progeria</a>.
Adult progeria is a rare genetic disorder characterized by premature aging starting in late adolescence or early adulthood.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45540026/exclusive-telomir-pharma-to-raise-3-million-via-equity-financing-to-fund-its-rare-disease-ind" rel="noreferrer noopener">EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND</a>
Werner Syndrome is caused by mutations in the wrn gene, which plays a critical role in DNA repair and telomere maintenance.
These findings confirm and build upon the company's previously reported results from a preclinical C. elegans study, which demonstrated that Telomir-1 restored lifespan and normalized physiological decline in animals with a wrn gene mutation.
<h2 class="wp-block-heading">Key Preclinical Findings</h2>
In this study, Telomir-1 reversed age-related hypomethylation at two chromosomal regions, restoring methylation patterns to above-normal wild-type levels.
This suggests that Telomir-1 may help restore healthy gene regulation and reset the body's epigenetic aging clock, reducing the risk of dysfunction in key biological systems.
Telomeres are the protective caps at the ends of chromosomes that shorten with each cell division and under stress. Telomere shortening is considered one of the hallmarks of aging.
In the study, Telomir-1 increased telomere length by about three-fold compared to the shortened length in the mutated animals. At the higher dose, telomere length significantly exceeded wild-type (healthy) levels,&nbsp;suggesting restoration and potential enhancement of chromosomal integrity.
In the wrn-mutant zebrafish model, animals exhibited a 50–60% reduction in body weight and muscle volume. After 14 days of Telomir-1 treatment, these physical markers were restored to levels statistically indistinguishable from healthy controls — indicating functional recovery and metabolic improvement.
Reactive oxygen species (ROS), which damage cells and accelerate aging, were elevated in untreated animals. Telomir-1 reduced ROS levels by up to 50%, suggesting improved cellular resilience.
Roughly 15% of untreated animals died during the 14-day study period, whereas no deaths occurred in any Telomir-1-treated groups.
In March, Telomir Pharmaceuticals revealed preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44394817/exclusive-telomir-pharmaceuticals-lead-drug-candidate-inhibits-tumor-growth-in-aggressive-prostate-cancer-cells-animal-study-shows" rel="noreferrer noopener">with aggressive cancer cells</a>.
The company says that Telomir-1 actively suppresses cancer growth and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel—a widely used chemotherapy but often associated with severe toxicity and side effects.
Price Action: TELO stock closed at $2.11 on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45781527/apple-app-store-sales-jump-in-may-boosting-outlook-for-services-growth">Apple App Store Sales Jump In May, Boosting Outlook For Services Growth</a></li>
</ul>

Biotech

Health Care

Market-Moving Exclusives

Exclusives

General

TELO

EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder

EXCLUSIVE: Telomir Pharmaceuticals Tells Benzinga 'Treatment restored gene control, extended telomere length beyond healthy levels, reversed muscle and weight loss, reduced oxidative stress, and resulted in 100% survival'

EXCLUSIVE: Telomir Pharmaceuticals Tells Benzinga Co. Announces Telomir-1 Resets The Body's Epigenetic Clock, Says Reverses DNA Methylation And Restores Youthful Gene Regulation In An Ultra-Rare Accelerated Aging Animal Model Of Werner Syndrome

BLDP

Ballard Power Systems Signs Supply Agreement With Sierra Northern Railway For Supply Of 1.5 MW Of Fuel Cell Engines, Expected To Be Delivered In 2025

Orders, Backlog and Fiscal 2026 Outlook
Orders in the first quarter of fiscal 2026 were $34.9 million, up from $33.1 million in the first quarter of fiscal 2025. The Company's order backlog was $25.5 million as of April 30, 2025, compared with $28.3 million at the end of fiscal 2025.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="19" rowspan="1">STRONOVA, INC.</td>
</tr>
<tr>
<td colspan="19" rowspan="1">Bookings and Backlog</td>
</tr>
<tr>
<td colspan="19" rowspan="1">(Unaudited, $ in thousands)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">Q1 FY25</td>
<td colspan="3" rowspan="1">Q2 FY25</td>
<td colspan="3" rowspan="1">Q3 FY25</td>
<td colspan="3" rowspan="1">Q4 FY25</td>
<td colspan="3" rowspan="1">FY 2025</td>
<td colspan="3" rowspan="1">Q1 FY26</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sales</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">32,961</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">40,539</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">40,422</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">37,361</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">151,283</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">37,708</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bookings</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">33,122</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">35,799</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">37,615</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">38,576</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">145,112</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">34,893</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Backlog</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">31,556</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">29,900</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">27,092</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">28,307</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">28,307</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$</td>
<td colspan="1" rowspan="1">25,491</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Book:Bill</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">100</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">88</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">103</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">96</td>
<td colspan="1" rowspan="1">%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93</td>
<td colspan="1" rowspan="1">%</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Comments

WGE Holdings

Notizie

Ultime notizie per WGE Holdings (OTC:WGEE) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO